Source: Blackbird

Press Release: Ironwood Pharmaceuticals : Allergan and Ironwood Launch Campaign Designed to Empower the Nearly 64 Million Americans Estimated to Suffer from IBS and CIC to Talk About Bowel Health(1-5)

DUBLIN and CAMBRIDGE, Mass., April 13, 2017 /PRNewswire/ - Allergan plc (NYSE: AGN) and Ironwood Pharmaceuticals Inc. (NASDAQ: IRWD), in partnership with the American Gastroenterological Association (AGA), initiated a campaign about the importance of bowel health in recognition of Irritable Bowel Syndrome (IBS) Awareness Month, at the Vital Signs of Bowel Health Summit, which took place yesterday ... Czytaj dalej Allergan and Ironwood Launch Campaign Designed to Empower the Nearly 64 Million Americans Estimated to Suffer from IBS and CIC to Talk About Bowel Health(1-5)

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Based on data from Ironwood's latest SEC filings

Annual Revenue

Based on data from Ironwood's latest SEC filings

Employees

Mark Mallon's photo - CEO of Ironwood

CEO

Mark Mallon

CEO Approval Rating

88/100

Ironwood is a drug manufacturer that develops and markets medicines for the treatment of irritable bowel syndrome and ch... Read more